Pteridines as FGFR inhibitors
US9447098B2 · kind B2 · utility
26Cited by
18References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 2013 |
| Grant date | Sep 20, 2016 |
| Priority date | — |
| Expiry date | May 30, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D475/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to new pteridine derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.